Breakthroughs in the treatment and prevention of Clostridium difficile infection
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breakthroughs in the treatment and prevention of Clostridium difficile infection
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 13, Issue 3, Pages 150-160
Publisher
Springer Nature
Online
2016-02-10
DOI
10.1038/nrgastro.2015.220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection
- (2016) Christine H. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection
- (2015) G. Cammarota et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fecal Microbiota Transplantation forClostridium difficileInfection
- (2015) Dimitri Drekonja et al. ANNALS OF INTERNAL MEDICINE
- Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection
- (2015) Thomas Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection
- (2015) Bruce E Hirsch et al. BMC INFECTIOUS DISEASES
- A randomised phase 1 study to investigate safety, pharmacokinetics and impact on gut microbiota following single and multiple oral doses in healthy male subjects of SMT19969, a novel agent for Clostridium difficile infections
- (2015) Richard Vickers et al. BMC INFECTIOUS DISEASES
- Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant
- (2015) M. Baxter et al. CLINICAL INFECTIOUS DISEASES
- Prevention of Clostridium difficile Infection With Probiotics
- (2015) Charlesnika T. Evans et al. CLINICAL INFECTIOUS DISEASES
- The Potential of Probiotics to Prevent Clostridium difficile Infection
- (2015) Stephen J. Allen INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- The Prospect for Vaccines to Prevent Clostridium difficile Infection
- (2015) Chandrabali Ghose et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfection
- (2015) Dale N. Gerding et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead
- (2015) Thomas Borody et al. Expert Review of Gastroenterology & Hepatology
- Weight Gain After Fecal Microbiota Transplantation
- (2015) N. Alang et al. Open Forum Infectious Diseases
- Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients
- (2014) Colleen R Kelly et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antibodies for Treatment of Clostridium difficile Infection
- (2014) David P. Humphreys et al. Clinical and Vaccine Immunology
- Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study
- (2014) Ilan Youngster et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis
- (2014) Gauree G. Konijeti et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
- (2014) Stuart Johnson et al. CLINICAL INFECTIOUS DISEASES
- Pediatric Clostridium difficile Infection: 6-Year Active Surveillance in a Defined Patient Population
- (2014) Nicole Le Saux et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Oral, Capsulized, Frozen Fecal Microbiota Transplantation for RelapsingClostridium difficileInfection
- (2014) Ilan Youngster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
- (2014) D. Nathwani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clostridium difficile Infection Among Children Across Diverse US Geographic Locations
- (2014) J. M. Wendt et al. PEDIATRICS
- Development of a recombinant toxin fragment vaccine for Clostridium difficile infection
- (2014) Jerzy Karczewski et al. VACCINE
- Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection
- (2014) L. K. Kociolek et al. Journal of the Pediatric Infectious Diseases Society
- Norovirus Gastroenteritis After Fecal Microbiota Transplantation for Treatment of Clostridium difficile Infection Despite Asymptomatic Donors and Lack of Sick Contacts
- (2013) Margot Schwartz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections
- (2013) Christina M Surawicz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea
- (2013) Bradley C. Johnston et al. ANNALS OF INTERNAL MEDICINE
- ComparativeIn VitroActivities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates
- (2013) Ellie J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Investigations of the Mode of Action and Resistance Development of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
- (2013) Lauren M. De Leon et al. Clinical Gastroenterology and Hepatology
- Is Fidaxomicin Worth the Cost? An Economic Analysis
- (2013) Sarah M. Bartsch et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories
- (2013) C.-A. D. Burnham et al. CLINICAL MICROBIOLOGY REVIEWS
- Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection
- (2013) Rodrigo Quera et al. Journal of Crohns & Colitis
- Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial
- (2013) Stephen J Allen et al. LANCET
- A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
- (2013) R. G. K. Donald et al. MICROBIOLOGY-SGM
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clostridium difficile Infection in Infants and Children
- (2013) PEDIATRICS
- Hyperimmune bovine colostrum for treatment of GI infections
- (2013) Jennifer Steele et al. Human Vaccines & Immunotherapeutics
- Epidemiology of Community-AssociatedClostridium difficileInfection, 2009 Through 2011
- (2013) Amit S. Chitnis et al. JAMA Internal Medicine
- Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
- (2012) Matthew J Hamilton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects
- (2012) Stephen A. Villano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
- (2012) T. J. Louie et al. CLINICAL INFECTIOUS DISEASES
- Current State of Clostridium difficile Treatment Options
- (2012) A. A. Venugopal et al. CLINICAL INFECTIOUS DISEASES
- Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain
- (2012) Laurica A. Petrella et al. CLINICAL INFECTIOUS DISEASES
- Burden of Clostridium difficile on the Healthcare System
- (2012) Erik R. Dubberke et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial
- (2012) E.G. Mima et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibody Against TcdB, but Not TcdA, Prevents Development of Gastrointestinal and Systemic Clostridium difficile Disease
- (2012) Jennifer Steele et al. JOURNAL OF INFECTIOUS DISEASES
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models
- (2012) Jing-Hui Tian et al. VACCINE
- Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine
- (2012) Richard N. Greenberg et al. VACCINE
- Clostridium difficile: Development of a novel candidate vaccine
- (2012) Ginamarie Foglia et al. VACCINE
- Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
- (2012) Trevor D. Lawley et al. PLoS Pathogens
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
- (2011) Johan S. Bakken et al. Clinical Gastroenterology and Hepatology
- Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
- (2011) Kathleen M. Mullane et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin: A Novel Macrocyclic Antibiotic Approved for Treatment of Clostridium difficile Infection
- (2011) A. A. Venugopal et al. CLINICAL INFECTIOUS DISEASES
- Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and B
- (2011) Patima Permpoonpattana et al. INFECTION AND IMMUNITY
- The host immune response to Clostridium difficile
- (2011) C. P. Kelly et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Changing Epidemiology of Clostridium difficile Infections
- (2010) J. Freeman et al. CLINICAL MICROBIOLOGY REVIEWS
- Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review
- (2010) Marwan S. Abougergi et al. DIGESTIVE DISEASES AND SCIENCES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toxin B is essential for virulence of Clostridium difficile
- (2009) Dena Lyras et al. NATURE
- Safety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers following Single and Multiple Oral Doses
- (2008) Y. K. Shue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection
- (2008) T. J. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated Diarrhea
- (2008) Ju Young Chang et al. JOURNAL OF INFECTIOUS DISEASES
- Clostridium difficile— More Difficult Than Ever
- (2008) Ciarán P. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial
- (2008) Eero Mattila et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation